Article Text

PDF
Magnetic resonance imaging in patients with rheumatoid arthritis with complete remission treated with disease-modifying antirheumatic drugs or anti-tumour necrosis factor α agents
  1. M U Martínez-Martínez1,
  2. E Cuevas-Orta1,
  3. G Reyes-Vaca1,
  4. L Baranda1,
  5. R González-Amaro2,
  6. C Abud-Mendoza1
  1. 1Regional Unit of Rheumatology and Osteoporosis, Hospital Central and Universidad Autónoma de San Luis Potosí, SLP, México
  2. 2Department of Immunology, Facultad de Medicina, Universidad Autónoma de San Luis Potosí, San Luis Potosí, SLP, México
  1. Correspondence to:
    Dr C Abud-Mendoza
    Regional Unit of Rheumatology and Osteoporosis, Hospital Central and Universidad Autónoma San Luis Potosí, SLP, México; c_abud{at}hotmail.com

Statistics from Altmetric.com

Biological treatment, mainly with anti-tumour necrosis factor (TNF)α agents, of patients with rheumatoid arthritis, has been shown to modify their clinical course and progression, and delay or avoid its radiological progression.1,2 Disease remission in rheumatoid arthritis has been traditionally considered when there is no clinical or biochemical evidence of disease activity.3

Magnetic resonance imaging (MRI) has been shown to be more sensitive than clinical and radiological parameters in evaluating the bone erosions and the inflammatory phenomenon that …

View Full Text

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.